Skip to Main Content
 
Thought Leadership

Part III - COVID-19 Testing Considerations for Pharmacists and Pharmacies

 
April 2020

Related Industry:

Healthcare

Related Service:

Pharmacy
 
Webinar

In the third installment of our COVID-19 discussion for pharmacies and pharmacists, we talk about the guidance recently issued by HHS related to the pharmacists’ ability to “order and administer” COVID-19 testing. We also discuss the HIPAA waiver for community-based testing sites. We cover CLIA waivers required for testing, the Boards of Pharmacy guidance related to pharmacist and pharmacy technician scope of practice, and other legal considerations. Finally, we end with general business considerations to contemplate before endeavoring to become a community-based testing site for COVID-19. 

Professionals:

Erica M. Ash

Associate
 

Stay updated.

Subscribe to receive Husch Blackwell’s news and insights.

Select your preferences